Acerta Pharma's Corporate Majority Round

Acerta Pharma raised a round of funding on December 17, 2015. Investors include AstraZeneca.

Acerta Pharma, a privately-owned biotech company that combines two technology platforms in drug discovery and development: the Covalent Technology Platform and the Multiparametric Phosphoflow Cytometr…

Articles about Acerta Pharma's Corporate Majority Round: